IRIS
LUCARELLI, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.441
AS - Asia 4.111
EU - Europa 2.701
SA - Sud America 1.177
AF - Africa 187
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 18.627
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.277
SG - Singapore 1.646
BR - Brasile 957
CN - Cina 884
HK - Hong Kong 530
IT - Italia 470
SE - Svezia 452
RU - Federazione Russa 431
VN - Vietnam 361
DE - Germania 327
FR - Francia 238
FI - Finlandia 206
GB - Regno Unito 188
IN - India 141
UA - Ucraina 139
BD - Bangladesh 95
CA - Canada 89
AR - Argentina 82
IQ - Iraq 67
BE - Belgio 62
ID - Indonesia 56
ZA - Sudafrica 48
MX - Messico 45
TR - Turchia 44
CO - Colombia 42
SA - Arabia Saudita 40
JP - Giappone 39
CI - Costa d'Avorio 37
PK - Pakistan 33
NL - Olanda 32
VE - Venezuela 28
EC - Ecuador 26
ES - Italia 26
IE - Irlanda 23
PL - Polonia 23
PH - Filippine 20
MA - Marocco 19
TN - Tunisia 18
UZ - Uzbekistan 18
KE - Kenya 14
EG - Egitto 13
IR - Iran 13
JO - Giordania 13
AE - Emirati Arabi Uniti 12
AT - Austria 12
LT - Lituania 12
MY - Malesia 12
NP - Nepal 10
AZ - Azerbaigian 9
CL - Cile 9
OM - Oman 9
PY - Paraguay 9
KR - Corea 8
UY - Uruguay 8
BO - Bolivia 7
CH - Svizzera 7
PE - Perù 7
TH - Thailandia 7
AL - Albania 6
DZ - Algeria 6
JM - Giamaica 6
KZ - Kazakistan 6
LB - Libano 6
PS - Palestinian Territory 6
AU - Australia 5
CZ - Repubblica Ceca 5
ET - Etiopia 5
HN - Honduras 5
IL - Israele 5
SN - Senegal 5
SY - Repubblica araba siriana 5
TT - Trinidad e Tobago 5
AO - Angola 4
BG - Bulgaria 4
BY - Bielorussia 4
CR - Costa Rica 4
GE - Georgia 4
RO - Romania 4
RS - Serbia 4
EE - Estonia 3
HR - Croazia 3
HU - Ungheria 3
KG - Kirghizistan 3
LV - Lettonia 3
AM - Armenia 2
EU - Europa 2
GA - Gabon 2
GT - Guatemala 2
LY - Libia 2
MD - Moldavia 2
MK - Macedonia 2
NG - Nigeria 2
PA - Panama 2
PT - Portogallo 2
RE - Reunion 2
SR - Suriname 2
SV - El Salvador 2
TW - Taiwan 2
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
Totale 18.599
Salva come PNG Salva come JPEG
Città #
Fairfield 1.261
Ashburn 1.149
Woodbridge 902
Singapore 894
Chandler 788
Houston 585
Hong Kong 529
Seattle 520
Cambridge 476
San Jose 428
Wilmington 387
Nyköping 357
Ann Arbor 326
Beijing 295
Jacksonville 276
New York 206
Bari 159
Los Angeles 156
Lawrence 155
Roxbury 155
Lauterbourg 147
Munich 118
Dallas 117
Ho Chi Minh City 117
Nanjing 113
São Paulo 104
Des Moines 99
Council Bluffs 83
Helsinki 81
Princeton 77
Santa Clara 69
Hanoi 68
Buffalo 61
Brussels 60
London 58
Boardman 57
Brooklyn 54
Inglewood 52
San Diego 50
Dearborn 44
Abidjan 37
Frankfurt am Main 37
Chicago 36
Jakarta 36
Shenyang 36
The Dalles 36
Dong Ket 35
Hebei 34
Columbus 33
Redwood City 32
Montreal 30
Tokyo 29
Turku 29
Rio de Janeiro 28
Nanchang 27
Paris 27
Orem 26
Baghdad 25
Pune 25
Brasília 24
Dublin 24
Jiaxing 24
Tianjin 24
Falkenstein 22
Toronto 22
Belo Horizonte 21
Boston 21
Campinas 21
Moscow 21
Changsha 19
Rome 19
Stockholm 19
Phoenix 18
Atlanta 17
Augusta 17
Chennai 17
Guangzhou 17
Mexico City 17
Warsaw 17
Curitiba 16
Johannesburg 16
Medellín 16
Caracas 15
Denver 15
Jeddah 15
Tashkent 15
Amsterdam 14
Bitonto 14
San Francisco 14
Bogotá 13
Dhaka 13
Falls Church 13
Shanghai 13
Buenos Aires 12
Da Nang 12
Manaus 12
Monmouth Junction 12
Nairobi 12
Nuremberg 12
Porto Alegre 12
Totale 12.918
Salva come PNG Salva come JPEG
Nome #
miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction 251
Renal progenitor cells revert LPS-induced endothelial-to-mesenchymal transition by secreting CXCL6, SAA4, and BPIFA2 antiseptic peptides 225
Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma. 219
Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma 206
Loss of STK11 expression is an early event in prostate carcinogenesis and predicts therapeutic response to targeted therapy against MAPK/p38. 202
Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell-Renal Cell Carcinoma 201
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 201
Complement Modulation of Anti-Aging Factor Klotho in Ischemia/Reperfusion Injury and Delayed Graft Function 199
Complement component C5a induces aberrant epigenetic modifications in renal tubular epithelial cells accelerating senescence by Wnt4/βcatenin signaling after ischemia/reperfusion injury 193
Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/ml. 191
Isolation and characterization of cancer stem cells in renal cell carcinoma. 187
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma 182
A single-center cohort study to define the role of pretransplant biopsy score in the long-term outcome of kidney transplantation. 179
Clinical management of a unique case of PNET of the uterus during pregnancy, and review of the literature 172
Recurrent urinary tract infections in kidney transplant recipients during the first-year influence long-term graft function: a single-center retrospective cohort study 171
Androgen deprivation therapy affects BCL-2 expression in human prostate cancer 170
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer 169
Renal Cell Carcinoma: A Study through NMR-Based Metabolomics Combined with Transcriptomics 167
Capillary hemangioma of the scrotum mimicking an epididymal tumor: case report. 165
Soluble Serum αklotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma 163
Pre-existing Type 2 Diabetes Mellitus Is an Independent Risk Factor for Mortality and Progression in Patients With Renal Cell Carcinoma. 160
Allograft nephrectomy: what is the best surgical technique? 160
Impact of donor-recipient gender on kidney graft and patient survival: short- and long-term outcomes. 159
Experience of percutaneous access under ultrasound guidance in renal transplant patients with allograft lithiasis 157
Complement activation during ischemia/reperfusion injury induces pericyte-to-myofibroblast transdifferentiation regulating peritubular capillary Lumen Reduction Through pERK Signaling 157
A challenging surgical approach to locally advanced primary urethral carcinoma: A case report and literature review 156
Penile prosthesis implant: when, what and how 154
Penile prosthesis implant for primary erectile dysfunction in patient with Klippel-Trenaunay syndrome complicated by consumptive coagulopathy: A case report 153
Microvascular density, macrophages, and mast cells in human clear cell renal carcinoma with and without bevacizumab treatment 151
Spondin-2, a Secreted Extracellular Matrix Protein, Is a Novel Diagnostic Biomarker for Prostate Cancer. 145
Androgen deprivation therapy regulation of beta 1C integrin expression in prostate cancer 142
SERUM SARCOSINE INCREASES THE ACCURACY OF PROSTATE CANCER DETECTION IN LOW RANGE PSA 141
Extended criteria donor kidney transplantation: comparative outcome analysis between single versus double kidney transplantation at 5 years 140
DelCFHR3-1 influences graft survival in transplant patients with IgA nephropathy via Complement-mediated cellular senescence 139
Serum sarcosine is a risk factor for progression and survival in patients with metastatic castration-resistant prostate cancer. 136
Emerging urinary markers of renal injury in obstructive nephropathy. 133
"Deviceless" hand-assisted laparoscopic donor nephrectomy 133
Diagnostic and prognostic role of preoperative circulating CA 15-3, CA 125, and beta-2 microglobulin in renal cell carcinoma. 133
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer 129
A CLUSTER OF PROTEINS SECRETED BY HUMAN RENAL STEM/PROGENITOR CELLS (ARPCS) PROVIDE A NOVEL STRATEGY TO REVERT ENDOTHELIAL DYSFUNCTION AND RENAL INJURY IN SEPSIS-INDUCED ACUTE KIDNEY INJURY (AKI) 127
Penile prosthesis: what should we do about complications? 126
Complement-Mediated Acute Induction of Endothelial-to-Mesenchymal Transition in a Swine Model of Renal Ischemia/Reperfusion (I/R) Injury 125
Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage 123
Integration of lipidomics and transcriptomics reveals reprogramming of the lipid metabolism and composition in clear cell renal cell carcinoma 123
Pentraxin-3-mediated complement activation in a swine model of renal ischemia/reperfusion injury 123
The emerging role of obesity, diet and lipid metabolism in prostate cancer 122
PTX3 modulates the immunoflogosis in tumor microenvironment and is a prognostic factor for patients with clear cell renal cell carcinoma 122
Incidental prostatic cancer: repeat TURP or biopsy? 120
null 119
DIABETES MELLITUS IN RENAL CELL CARCINOMA: ROLE OF OGG1 AND TUBERIN 119
DIABETES MELLITUS IS A RISK FACTOR FOR RECURRENCE AND MORTALITY IN PATIENTS WITH RENAL CELL CARCINOMA . 119
Transperineal interstitial laser ablation of the prostate, a novel option for minimally invasive treatment of benign prostatic obstruction 118
Statin use and survival in patients with metastatic castrationresistant prostate cancer treated with abiraterone or enzalutamide after docetaxel failure: The international retrospective observational STABEN study 117
Emerging biomarkers in renal damage. 116
Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance 116
Adding systematic biopsy to magnetic resonance ultrasound fusion targeted biopsy of the prostate in men with previous negative biopsy or enrolled in active surveillance programs: A prospective single center, randomized study 116
Patient and partner satisfaction after AMS inflatable penile prosthesis implant 115
Metabolomic insights into pathophysiological mechanisms and biomarker discovery in clear cell renal cell carcinoma 115
Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non–muscle-invasive Bladder Cancer 114
Editorial comment from Dr Lucarelli and Dr Ditonno to Impact of graft nephrectomy on outcomes of second kidney transplantation. 113
Endothelial-to-mesenchymal transition and renal fibrosis in ischaemia/reperfusion injury are mediated by complement anaphylatoxins and Akt pathway 113
Middle and long-term outcomes of dual kidney transplant: a multicenter experience 111
Novel Insights into Autophagy and Prostate Cancer: A Comprehensive Review 111
Management of severe complications following penile surgery for erectile dysfunction and Peyronie disease: Three case reports 110
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 110
Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer 110
null 109
Long-term results of radical surgery and adjuvant radiotherapy in a case of primary malignant fibrous histiocytoma of the kidney 106
B3 Adrenergic Receptor Agonist Mirabegron Increases AQP2 and NKCC2 Urinary Excretion in OAB Patients: A Pleiotropic Effect of Interest for Patients with X-Linked Nephrogenic Insipidus 105
Bladder Metastases from Lung Cancer: Clinical and Pathological Implications: A Systematic Review 105
Aligned Nanofiber Topographies Enhance the Differentiation of Adult Renal Stem Cells into Glomerular Podocytes 103
Transperitoneal deviceless hand-assisted laparoscopic living donor nephrectomy: an alternative technique for kidney recovery 102
36-kDa Annexin A3 Isoform Negatively Modulates Lipid Storage in Clear Cell Renal Cell Carcinoma Cells 102
Testicular granulosa cell tumor of adult type: a new case and a review of the literature 101
Hem-O-Lok clip: A neglected cause of severe bladder neck contracture and consequent urinary incontinence after robot-assisted laparoscopic radical prostatectomy 101
Obesity in kidney transplantation affects renal function but not graft and patient survival 101
Incidentally discovered yellowish lesions in a renal graft from a deceased donor 101
Modified glasgow prognostic score is associated with risk of recurrence in bladder cancer patients after radical Cystectomy: A multicenter experience 100
Complement Mediated Endothelial Cell (EC) Activation in a Swine Model of Renal Ischemia/Reperfusion (I/R) Injury 100
ASSOCIATION OF N-ACETYLTRANSFERASE 2 POLYMORPHISM WITH RISK FACTORS IN UROTHELIAL CANCER. 98
LAMININA 5 COME MARKER NELLA DIAGNOSI E NELLA PROGNOSI DEL CARCINOMA UROTELIALE DELLA VESCICA 98
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis 97
An evaluation of UGN-101, a sustained-release hydrogel polymer-based formulation containing mitomycin-C, for the treatment of upper urothelial carcinomas 97
Impact of transplant nephrectomy on retransplantation: a single-center retrospective study. 96
MP067 MICRORNA PROFILING USING NEXT-GENERATION SEQUENCING IN RENAL CANCER STEM CELLS: A NEW REGULATORY MECHANISM 96
MUC1 Expression Affects the Immunoflogosis in Renal Cell Carcinoma Microenvironment through Complement System Activation and Immune Infiltrate Modulation 95
Unusual solitary metastasis of the ciliary body in renal cell carcinoma 95
DIABETES MELLITUS IS A RISK FACTOR FOR PROGRESSION IN RENAL CELL CARCINOMA 93
RENAL CELL CARCINOMA: DOES TRANSCRIPTIONAL DEREGULATION OF ADULT RENAL STEM/PROGENITOR CELLS LEAD TO ONCOGENESIS? 93
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets 91
Ischemia-Reperfusion Injury in Kidney Transplantation: Mechanisms and Potential Therapeutic Targets. 90
Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population. 90
THE DIAGNOSTIC ROLE OF CA 15-3, CA 125 AND BETA2-MICROGLOBULIN IN RENAL CELL CARCINOMA 88
Delayed relief of ureteral obstruction is implicated in the long-term development of renal damage and arterial hypertension in patients with unilateral ureteral injury 87
64CuCl2 PET/CT as a potential new imaging method in prostate cancer: illusion or reality? 87
null 86
CARCINOMA DELLA PROSTATA 85
Surgery for renal cell carcinoma in two European urologic clinics: to compare or compete? 85
Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an update 84
Extended Criteria Donor Kidney Transplantation: Comparative Outcome Analysis of Score 4 Graft Used as Single Transplant Versus Double Kidney Transplantation 83
Totale 13.014
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.266
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.266
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021546 0 0 0 0 0 0 0 0 0 212 215 119
2021/20221.109 71 95 18 35 42 103 42 64 71 118 164 286
2022/20231.890 288 228 129 171 187 259 25 239 279 16 45 24
2023/2024663 65 120 38 49 57 230 10 13 5 14 11 51
2024/20253.069 70 73 221 124 88 285 371 271 114 134 455 863
2025/20265.801 1.015 306 449 751 812 359 673 214 631 591 0 0
Totale 19.211